Cargando…

The Dutch Consumer Quality Index: an example of stakeholder involvement in indicator development

BACKGROUND: Like in several other Western countries, in the Dutch health care system regulated competition has been introduced. In order to make this work, comparable information is required about the performance of health care providers in terms of effectiveness, safety and patient experiences. Wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Delnoij, Diana MJ, Rademakers, Jany JDJM, Groenewegen, Peter P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864255/
https://www.ncbi.nlm.nih.gov/pubmed/20370925
http://dx.doi.org/10.1186/1472-6963-10-88
_version_ 1782180764177137664
author Delnoij, Diana MJ
Rademakers, Jany JDJM
Groenewegen, Peter P
author_facet Delnoij, Diana MJ
Rademakers, Jany JDJM
Groenewegen, Peter P
author_sort Delnoij, Diana MJ
collection PubMed
description BACKGROUND: Like in several other Western countries, in the Dutch health care system regulated competition has been introduced. In order to make this work, comparable information is required about the performance of health care providers in terms of effectiveness, safety and patient experiences. Without further coordination, external actors will all try to force health care providers to be transparent. For health care providers this might result in a situation in which they have to deliver data for several sets of indicators, defined by different actors. Therefore, in the Netherlands an effort is made to define national sets of performance indicators and related measuring instruments. In this article, the following questions are addressed, using patient experiences as an example: - When and how are stakeholders involved in the development of indicators and instruments that measure the patients' experiences with health care providers? - Does this involvement lead to indicators and instruments that match stakeholders' information needs? DISCUSSION: The Dutch experiences show that it is possible to implement national indicator sets and to reach consensus about what needs to be measured. Preliminary evaluations show that for health care providers and health insurers the benefits of standardization outweigh the possible loss of tailor-made information. However, it has also become clear that particular attention should be given to the participation of patient/consumer organisations. SUMMARY: Stakeholder involvement is complex and time-consuming. However, it is the only way to balance the information needs of all the parties that ask for and benefit from transparency, without frustrating the health care system.
format Text
id pubmed-2864255
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28642552010-05-05 The Dutch Consumer Quality Index: an example of stakeholder involvement in indicator development Delnoij, Diana MJ Rademakers, Jany JDJM Groenewegen, Peter P BMC Health Serv Res Debate BACKGROUND: Like in several other Western countries, in the Dutch health care system regulated competition has been introduced. In order to make this work, comparable information is required about the performance of health care providers in terms of effectiveness, safety and patient experiences. Without further coordination, external actors will all try to force health care providers to be transparent. For health care providers this might result in a situation in which they have to deliver data for several sets of indicators, defined by different actors. Therefore, in the Netherlands an effort is made to define national sets of performance indicators and related measuring instruments. In this article, the following questions are addressed, using patient experiences as an example: - When and how are stakeholders involved in the development of indicators and instruments that measure the patients' experiences with health care providers? - Does this involvement lead to indicators and instruments that match stakeholders' information needs? DISCUSSION: The Dutch experiences show that it is possible to implement national indicator sets and to reach consensus about what needs to be measured. Preliminary evaluations show that for health care providers and health insurers the benefits of standardization outweigh the possible loss of tailor-made information. However, it has also become clear that particular attention should be given to the participation of patient/consumer organisations. SUMMARY: Stakeholder involvement is complex and time-consuming. However, it is the only way to balance the information needs of all the parties that ask for and benefit from transparency, without frustrating the health care system. BioMed Central 2010-04-06 /pmc/articles/PMC2864255/ /pubmed/20370925 http://dx.doi.org/10.1186/1472-6963-10-88 Text en Copyright ©2010 Delnoij et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Debate
Delnoij, Diana MJ
Rademakers, Jany JDJM
Groenewegen, Peter P
The Dutch Consumer Quality Index: an example of stakeholder involvement in indicator development
title The Dutch Consumer Quality Index: an example of stakeholder involvement in indicator development
title_full The Dutch Consumer Quality Index: an example of stakeholder involvement in indicator development
title_fullStr The Dutch Consumer Quality Index: an example of stakeholder involvement in indicator development
title_full_unstemmed The Dutch Consumer Quality Index: an example of stakeholder involvement in indicator development
title_short The Dutch Consumer Quality Index: an example of stakeholder involvement in indicator development
title_sort dutch consumer quality index: an example of stakeholder involvement in indicator development
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864255/
https://www.ncbi.nlm.nih.gov/pubmed/20370925
http://dx.doi.org/10.1186/1472-6963-10-88
work_keys_str_mv AT delnoijdianamj thedutchconsumerqualityindexanexampleofstakeholderinvolvementinindicatordevelopment
AT rademakersjanyjdjm thedutchconsumerqualityindexanexampleofstakeholderinvolvementinindicatordevelopment
AT groenewegenpeterp thedutchconsumerqualityindexanexampleofstakeholderinvolvementinindicatordevelopment
AT delnoijdianamj dutchconsumerqualityindexanexampleofstakeholderinvolvementinindicatordevelopment
AT rademakersjanyjdjm dutchconsumerqualityindexanexampleofstakeholderinvolvementinindicatordevelopment
AT groenewegenpeterp dutchconsumerqualityindexanexampleofstakeholderinvolvementinindicatordevelopment